Trials / Completed
CompletedNCT00683384
Study Evaluating the Safety of Enbrel (Etanercept)
A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept (Enbrel) |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-05-23
- Last updated
- 2010-11-16
- Results posted
- 2010-11-16
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT00683384. Inclusion in this directory is not an endorsement.